# Republic of Moldova Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Republic of Moldova HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Republic of Moldova (MDA)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $6.3M
- Products: 16
- Buyer markets: 28
- Average CAGR: +57.5%
- Global sector size: $471.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $297.0B | $5.3M | $104.8B | +5.5% | 25 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $46.5B | $6.4K | $15.9B | +89.2% | 5 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $27.7B | $7.6K | $15.2B | +69.8% | 8 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $26.5B | $346.3K | $11.4B | +15.3% | 9 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $23.0B | $43.0K | $10.0B | +0.8% | 8 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $11.9B | $271.6K | $7.2B | +341.3% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $4.4B | $146.2K | $6.0B | +37.0% | 1 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $9.1B | $66.5K | $5.4B | +80.0% | 6 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $293.6 | $4.9B | +247.5% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | $16.5 | $4.6B | +19.5% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $6.1B | $79.6K | $3.7B | +37.6% | 5 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $228.8 | $2.0B | -7.5% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $25.8 | $981.1M | -16.6% | 1 | +0.0% |
| HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | $7.9 | $746.4M | +8.1% | 1 | +0.0% |
| HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $3.2K | $579.1M | -2.0% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $899.8M | $862.0 | $570.1M | +315.1% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $39.8B calculated opportunity across 10 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Germany (DEU): $23.9B calculated opportunity across 10 products.
- Netherlands (NLD): $17.8B calculated opportunity across 7 products.
- China (CHN): $11.3B calculated opportunity across 4 products.
- Canada (CAN): $8.4B calculated opportunity across 5 products.
- Spain (ESP): $8.4B calculated opportunity across 4 products.
- Belgium (BEL): $7.9B calculated opportunity across 2 products.
- United Kingdom (GBR): $7.9B calculated opportunity across 5 products.
- Italy (ITA): $6.8B calculated opportunity across 4 products.
- Ireland (IRL): $4.7B calculated opportunity across 3 products.
- France (FRA): $4.0B calculated opportunity across 2 products.

## Growth stars

- HS 330300: +341.3% average CAGR, $7.2B calculated opportunity.
- HS 300439: +315.1% average CAGR, $570.1M calculated opportunity.
- HS 300214: +247.5% average CAGR, $4.9B calculated opportunity.
- HS 300215: +89.2% average CAGR, $15.9B calculated opportunity.
- HS 382499: +80.0% average CAGR, $5.4B calculated opportunity.
- HS 300212: +69.8% average CAGR, $15.2B calculated opportunity.
- HS 300290: +37.6% average CAGR, $3.7B calculated opportunity.
- HS 330210: +37.0% average CAGR, $6.0B calculated opportunity.
- HS 293499: +19.5% average CAGR, $4.6B calculated opportunity.
- HS 330499: +15.3% average CAGR, $11.4B calculated opportunity.

## Diversification opportunities

- HS 300490: 25 buyer markets, $104.8B calculated opportunity.
- HS 330499: 9 buyer markets, $11.4B calculated opportunity.
- HS 300212: 8 buyer markets, $15.2B calculated opportunity.
- HS 382200: 8 buyer markets, $10.0B calculated opportunity.
- HS 330300: 6 buyer markets, $7.2B calculated opportunity.
- HS 382499: 6 buyer markets, $5.4B calculated opportunity.
- HS 300215: 5 buyer markets, $15.9B calculated opportunity.
- HS 300290: 5 buyer markets, $3.7B calculated opportunity.
- HS 330210: 1 buyer markets, $6.0B calculated opportunity.
- HS 300214: 1 buyer markets, $4.9B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.